High KRAS expression levels correlated with OS in ACC, ESCA, KIRC, PAAD and THYM of 0.01, 0.01, 0.001, 0.022, 0.035 and 0.005, respectively (Figures 3E–J); correlated with poor DSS in ACC, ESCA, KIRC, KIPP, MESO and PAAD by 0.002, 0.036, 0.004, 0.010, 0.038 and 0.039, respectively (Figures 2K–P); correlated with poor DFI in ACC, LGG, LUAD, OV and PAAD by 0.026, 0.005, 0.004 m 0.046 and 0.001, respectively (Figures 2Q–U); and correlated with poor PFI in ACC, CESC, KIRC, KIPP, PAAD and SARC by 0.005, 0.028, 0.001, 0.007, 0.020 and 0.042, respectively (Figure 2 V-AA). This evidence concerns the gene KRAS and adrenal cortex carcinoma.